Clin Mol Hepatol.  2013 Jun;19(2):173-178. 10.3350/cmh.2013.19.2.173.

Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma

Affiliations
  • 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. sw.paik@samsung.com
  • 2Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic carcinoma whose morphology is similar to that of hepatocellular carcinoma (HCC). Metachronous HCC and HAC in the same patient is extremely rare. The case of a 68-year-old man with chronic hepatitis B infection who had both HCC and HAC of the stomach is reported herein. Nine years previously this patient had been diagnosed with HCC and received a right lobectomy. HCC that recurred at the caudate lobe at 6 months after the operation was successfully treated with transarterial chemoembolization. The patient was followed up regularly thereafter without evidence of tumor recurrence for 9 years. In July 2010 his serum alpha-fetoprotein (AFP) level elevated from 6.5 ng/mL to 625.4 ng/mL, and he developed a probable single metastatic lymph node around the hepatic artery without intrahepatic lesions. Subsequent evaluation with upper endoscopy revealed a 4-cm ulcerative lesion on the antrum of the stomach. Subtotal gastrectomy was performed with lymph-node dissection. Histologic examination revealed a special type of extrahepatic AFP-producing adenocarcinoma-HAC with lymph-node metastasis-which indicates that HAC can be a cause of elevated AFP even in patients with HCC. HAC should be considered if a patient with stable HCC exhibits unusual elevation of AFP.

Keyword

Hepatoid adenocarcinoma; Hepatocellular carcinoma; Stomach; Metachronous

MeSH Terms

Adenocarcinoma/*diagnosis/drug therapy/secondary
Aged
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Camptothecin/analogs & derivatives/therapeutic use
Carcinoma, Hepatocellular/*diagnosis/drug therapy/pathology
Chemoembolization, Therapeutic
Chemotherapy, Adjuvant
Fluorouracil/therapeutic use
Gastroscopy
Humans
Leucovorin/therapeutic use
Liver Neoplasms/*diagnosis/drug therapy/pathology
Lymph Nodes/surgery
Lymphatic Metastasis
Male
Recurrence
Silicates/therapeutic use
Stomach Neoplasms/*diagnosis/drug therapy/secondary
Titanium/therapeutic use
Tomography, X-Ray Computed
alpha-Fetoproteins/*analysis
Silicates
alpha-Fetoproteins
Titanium
Leucovorin
Fluorouracil
Camptothecin
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr